Mapmygenome
Mapmygenome is a Hyderabad-based molecular diagnostics company offering at-home DNA testing kits and clinical genomic services through CAP and NABL accredited labs, serving health-conscious consumers, clinicians, and reproductive health markets across India and, since May 2025, North America via its Microbiome Insights subsidiary.
- Company typePrivate
- Founded2013
- HeadquartersHyderabad, India
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What Mapmygenome does
Mapmygenome is an India-headquartered molecular diagnostics company founded in 2013 (per company history; firmographics lists 2012) and based in Hyderabad, operating with 11-50 employees. It provides direct-to-consumer at-home DNA testing kits and clinical-grade diagnostic genomic services through a multi-omics platform that integrates DNA sequencing, epigenetics, and gut microbiome metagenomics. Core products include Genomepatri (polygenic risk score-based wellness planning), MapmyBiome (shotgun-sequenced gut microbiome analysis), MedicaMap (pharmacogenomics across 165+ medications), MapmyEpigenome (biological age via DNA methylation), and MapmySpark (mitochondrial wellness and maternal ancestry). Clinical offerings include Whole Exome Sequencing, Whole Genome Sequencing at 30x coverage, NIPT, and Hereditary Cancer Panels sold through a separate doctor-prescribed channel.
The company operates NABL and CAP dual-accredited laboratories in India and acquired Canada's Microbiome Insights in May 2025 to establish North American operations. Business model is predominantly transactional DTC e-commerce (one-time kit purchases priced Rs. 6,999 to Rs. 200,000), augmented by clinical diagnostic sales through healthcare providers and a premium bundle strategy (Stay Young, Live Long, Ultimate Biohacking). All tests include genetic counseling and the platform accepts raw data uploads from 9 competitor services including 23andMe and Ancestry. Key differentiators are India-specific PRS calibration and a proprietary 20,000+ record Indian subpopulation ancestry database, addressing underrepresentation of South Asian genomes in global datasets. Compliance posture spans ISO 15189, ISO 27001, ISO 20000-1, HIPAA, GDPR, and DPDP.
Mapmygenome firmographics
Firmographics- Name
- Mapmygenome
- Legal name
- Mapmygenome India
- Website
- https://mapmygenome.in
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Mapmygenome is a Hyderabad-based molecular diagnostics company offering at-home DNA testing kits and clinical genomic services through CAP and NABL accredited labs, serving health-conscious consumers, clinicians, and reproductive health markets across India and, since May 2025, North America via its Microbiome Insights subsidiary.
- Ownership category
- akta.pro rank
Mapmygenome industry classification
Industry- Product category
- Genomic Testing Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)
- akta.pro secondary industries
- Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Genetic & Prenatal Testing Laboratories (HLAFAMAH), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA)
Keywords
Where Mapmygenome is headquartered
LocationHeadquarters
- HQ city
- Hyderabad
- HQ country
- India
- HQ region
- Asia
Offices3 records
Markets served
Mapmygenome business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- At-Home DNA Testing Kits: One-time purchase of DNA testing kits with analysis and digital report delivery. Includes genetic counseling session. Products include Genomepatri, MapmyBiome, MedicaMap, MapmyEpigenome, and specialized tests.
- Premium Bundles and Programs: Bundled product packages combining multiple tests (Stay Young, Ultimate Biohacking, Live Long) at discounted rates versus individual purchases
- Diagnostic Genomic Tests: Clinical-grade diagnostic tests including Whole Exome Sequencing, Whole Genome Sequencing, Hereditary Cancer Panels, and NIPT sold through doctor-prescribed channel
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Genomepatri - Core DNA wellness test covering traits, nutrition, disease risk, and drug response |
| One time/ perpetual license | Pay-as-you-go | MapmyBiome - Gut microbiome test with shotgun sequencing |
| One time/ perpetual license | Pay-as-you-go | MedicaMap - Pharmacogenomic drug response test covering 165+ medications |
| One time/ perpetual license | Pay-as-you-go | MapmyEpigenome - Biological age and aging analysis |
| One time/ perpetual license | Pay-as-you-go | Whole Exome Sequencing - Comprehensive clinical genetic analysis |
| One time/ perpetual license | Pay-as-you-go | Whole Genome Sequencing - Complete genome analysis at 30x coverage |
| One time/ perpetual license | Pay-as-you-go | NIPT - Non-Invasive Prenatal Testing |
| One time/ perpetual license | Pay-as-you-go | Hereditary Cancer Panel - Cancer risk DNA test |
| One time/ perpetual license | Pay-as-you-go | MapmySpark - Mitochondrial wellness and heritage report |
| One time/ perpetual license | Pay-as-you-go | MatchmyGenome - Couple carrier screening |
| One time/ perpetual license | Pay-as-you-go | Ultimate Biohacking Package Phase I - Foundational multi-omics testing |
| One time/ perpetual license | Pay-as-you-go | Live Long Bundle - Genetics, Microbiome, Epigenetics combined |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Mapmygenome product offering
Product offeringCore offering
Mapmygenome offers direct-to-consumer at-home DNA testing kits (e.g., Genomepatri, MapmyBiome) and clinical diagnostic genomic tests (e.g., NIPT, Hereditary Cancer Panel, Whole Exome/Genome Sequencing) ordered through healthcare providers. The company provides end-to-end services including sample collection, multi-omics analysis (genomics, microbiome, epigenomics), polygenic risk score reporting, and genetic counseling.
Product overview
Mapmygenome is a multi-omics genomics company offering a comprehensive portfolio of at-home DNA testing products and clinical diagnostic services. The core product line includes Genomepatri (DNA-based wellness planner), MapmyBiome (gut microbiome analysis), MedicaMap (pharmacogenomics), and MapmyEpigenome (biological age testing). These are complemented by specialized products including ancestry analysis (Genomepatri Heritage), mitochondrial wellness (MapmySpark), fitness nutrition (Myfitgene), and beauty (Beautymap). For clinical diagnostics, the company provides Whole Exome Sequencing, Whole Genome Sequencing, Hereditary Cancer Panel, NIPT prenatal testing, Cardiomap, and MatchmyGenome carrier screening. Premium bundled offerings like the Ultimate Biohacking Package Phase I combine multiple testing modalities (genomic, microbiome, epigenomic) into unified health optimization programs. The company operates CAP and NABL accredited laboratories and has expanded internationally through acquisition of Microbiome Insights (Canada).
Differentiator
Problem solved
Functional benefit
Brands
- Genomepatri: DNA-based wellness planner that provides personalized health risk assessment, nutrition and fitness insights, disease risk prediction, and medication response analysis
- MapmyBiome
- MedicaMap
- MapmyEpigenome
- MapmySpark
- Myfitgene
- Beautymap
- Cardiomap
- Microbiome Insights
Products and services
- Genomepatri
- Genomepatri Heritage
- MapmyBiome
- MedicaMap
- MapmyEpigenome Advanced
- MapmySpark
- Whole Exome Sequencing
- Whole Genome Sequencing
- Hereditary Cancer Panel
- Non-Invasive Prenatal Testing (NIPT)
- Cardiomap
- Beautymap
- Myfitgene
- MatchmyGenome
- Ultimate Biohacking Package Phase I
- Stay Young Bundle
- Stay Informed Bundle
- Discover Yourself Bundle
- Look Better Bundle
- Live Long Bundle
Quantifiable outcome
- Over 100,000 genomes interpreted by team
- +1 more outcomes
Companies that use Mapmygenome
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Mapmygenome technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration9 records
AI capability4 records
Feature7 records
Mapmygenome partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Microbiome InsightscoreAcquired Canadian microbial sequencing company Microbiome Insights in May 2025 to gain access to CAP-accredited laboratory and expand into the US market. The acquisition enhances microbiome testing services for North America by leveraging Microbiome Insights' expertise in microbial genomics and positions Mapmygenome as a leader in microbiome health and integrated genomics services.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
Mapmygenome competitors and assessment
Company assessmentEmerging players
- Color Genomics: US clinical genetic testing company offering hereditary cancer, cardiovascular, and pharmacogenomic tests through employers and providers. Comparable to Mapmygenome's clinical channel (Hereditary Cancer Panel, MedicaMap) via a B2B2C distribution model.
- Nebula Genomics: US-based DTC whole-genome sequencing company offering deep-coverage sequencing at consumer price points. Comparable to Mapmygenome's Whole Genome Sequencing product for the international tech-savvy customer base.
Broad incumbents
- MyHeritage: Global genealogy and DNA testing platform with strong ancestry and family-tree focus. Mapmygenome accepts raw data uploads from MyHeritage and competes for the ancestry-driven segment through Genomepatri Heritage.
- 23andMe: Largest global DTC genetic testing company offering ancestry and health predisposition reports. Mapmygenome accepts raw data uploads from 23andMe and competes for the same Indian wellness customer, though 23andMe lacks India-specific PRS calibration.
- Ancestry: Global leader in ancestry DNA testing with the largest consumer genetic database. Mapmygenome competes for ancestry-driven Indian customers through Genomepatri Heritage, where its India-specific subpopulation database is a key differentiator.
Regional players
- Prenetics: Hong Kong-listed genomics and preventive health company offering DNA testing, NIPT, and consumer health products across Asia. Regional competitor with comparable multi-omics ambitions and a Hong Kong/SEA geographic focus.
- Circle DNA: Asia-focused (Hong Kong) premium genetic testing brand offering whole genome sequencing and health reports. Operates in the same premium-APAC wellness segment as Mapmygenome's international storefront but is primarily Greater China/Southeast Asia focused.
Direct peers
- MedGenome: India-headquartered genomics and molecular diagnostics company offering genetic testing, NIPT, hereditary cancer panels, and clinical interpretation. Direct competitor in the Indian genetic diagnostics market across both DTC and clinical channels.
- Strand Life Sciences: India-based clinical genomics and bioinformatics company providing genetic testing, NIPT, prenatal screening, and oncology panels. Competes head-to-head with Mapmygenome in India for clinical genomic testing services.
- Xcode Life: Chennai-based DTC genetic testing company focused on South Asian consumers, offering nutrigenomics, fitness, and ancestry tests. Direct competitor in the Indian DTC wellness genomics niche with overlapping product positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Mapmygenome social profiles
Digital presenceMapmygenome compliance and trust
Trust signalCompliance9 records
Mapmygenome financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mapmygenome leadership team
Management profileNumber of profiles
Profiles13 records
Mapmygenome subsidiaries and ownership
Company hierarchySubsidiaries1 record
Mapmygenome funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mapmygenome M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mapmygenome
What does Mapmygenome do?
Mapmygenome offers direct-to-consumer at-home DNA testing kits (e.g., Genomepatri, MapmyBiome) and clinical diagnostic genomic tests (e.g., NIPT, Hereditary Cancer Panel, Whole Exome/Genome Sequencing) ordered through healthcare providers. The company provides end-to-end services including sample collection, multi-omics analysis (genomics, microbiome, epigenomics), polygenic risk score reporting, and genetic counseling.
Is Mapmygenome a public or private company?
Mapmygenome is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Mapmygenome founded?
Mapmygenome was founded in 2013. It employs 11 to 50 people.
Where is Mapmygenome based?
Mapmygenome is headquartered in Hyderabad, India, in the Asia region.
How does Mapmygenome make money?
Three revenue lines are on record. At-Home DNA Testing Kits are the primary driver. The others are premium Bundles and Programs and diagnostic Genomic Tests.
Who are Mapmygenome's main competitors?
Emerging players on record are Color Genomics and Nebula Genomics. Broad incumbents are MyHeritage, 23andMe and Ancestry. Regional players are Prenetics and Circle DNA. Direct peers are MedGenome, Strand Life Sciences and Xcode Life.
Does Mapmygenome have an API?
No public API is recorded for Mapmygenome.
What industry is Mapmygenome in?
Mapmygenome's product category is Genomic Testing Services. Its primary akta.pro industry code is HLAFAMAE, Molecular Diagnostics & Genomics Laboratories, with a secondary code of HLAHAAAI, Genetic, Cytogenetic & Prenatal Screening IVD. Its NAICS code is 621511 and its SIC code is 8071.